FDA.reportPublic FDA data

TYLOXAPOL

Substance profile for UNII Y27PUL9H56, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#

UNII
Y27PUL9H56
Preferred term
TYLOXAPOL
Registry number
25301-02-4
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
Polymer substance not supported

Chemical And Database Identifiers#

RxCUI
38998
PubChem
0
NCIt
C80949
INN ID
1435

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
RxNorm38998mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=38998
NCI ThesaurusC80949ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C80949
FDA Substance Registration SystemY27PUL9H56precision.fda.gov/uniisearch/srs/unii/Y27PUL9H56

DailyMed Socrata Ingredients#

DailyMed label, SPL version table
DailyMed labelSPL version
Tobramycin Ophthalmic Solution, USP 0.3%–Sterile1
TOBRAMYCIN3
ALREX loteprednol etabonate ophthalmic suspension, 0.2%2
ALREX loteprednol etabonate ophthalmic suspension, 0.2%1
Tobramycin Ophthalmic Solution, USP 0.3%–Sterile1
TobraDex® (tobramycin and dexamethasone ophthalmic suspension) Sterile1
Tobramycin Ophthalmic Solution USP, 0.3% (Sterile)1
Tobramycin Ophthalmic Solution USP, 0.3% (Sterile)1
Tobramycin and Dexamethasone Ophthalmic Suspension Sterile2
These highlights do not include all the information needed to use nevanac safely and effectively. See full prescribing information for nevanac. nevanac (nepafenac) suspension for ophthalmic use Initial U.S. Approval: 20051
CIPRODEX® (ciprofloxacin 0.3% and dexamethasone 0.1%) Sterile Otic Suspension1
TobraDex1
3e64e493-ef35-43b9-b08c-3c30fe4a71641
Tobramycin Ophthalmic Solution USP, 0.3%1
LOTEMAX® loteprednol etabonate ophthalmic suspension, 0.5%1
MOXEZA (MOXIFLOXACIN HYDROCHLORIDE) SOLUTION [ALCON LABORATORIES, INC.]12
ALREX (LOTEPREDNOL ETABONATE) SUSPENSION/ DROPS [BAUSCH & LOMB INCORPORATED]8
SIMBRINZA (BRINZOLAMIDE/BRIMONIDINE TARTRATE) SUSPENSION/ DROPS [ALCON LABORATORIES, INC.]8
LOTEMAX (LOTEPREDNOL ETABONATE) SUSPENSION/ DROPS [BAUSCH & LOMB INCORPORATED]7
PROLENSA (BROMFENAC SODIUM) SOLUTION/ DROPS [BAUSCH & LOMB INCORPORATED]7
AZOPT (BRINZOLAMIDE) SUSPENSION [ALCON LABORATORIES, INC.]6
TOBRADEX ST (TOBRAMYCIN / DEXAMETHASONE) SUSPENSION [ALCON LABORATORIES, INC.]6
LOTEMAX (LOTEPREDNOL ETABONATE) GEL [BAUSCH & LOMB INCORPORATED]5
NEVANAC (NEPAFENAC) SUSPENSION/ DROPS [ALCON LABORATORIES, INC.]5
TOBRAMYCIN SOLUTION [BAUSCH & LOMB INCORPORATED]5
TOBREX (TOBRAMYCIN) SOLUTION [ALCON LABORATORIES, INC.]5
GENTAMICIN SULFATE SOLUTION [SANDOZ INC]4
TOBRAMYCIN AND DEXAMETHASONE SUSPENSION/ DROPS [BAUSCH & LOMB INCORPORATED]4
ALOMIDE (LODOXAMIDE TROMETHAMINE) SOLUTION/ DROPS [ALCON LABORATORIES, INC.]3
CIPRODEX (CIPROFLOXACIN AND DEXAMETHASONE) SUSPENSION [ALCON, INC.]3
RETAINE MGD (MINERAL OIL) EMULSION [OCUSOFT, INC.]3
TOBRADEX (TOBRAMYCIN AND DEXAMETHASONE) SUSPENSION/ DROPS [ALCON LABORATORIES, INC.]3
TOBRAMYCIN AND DEXAMETHASONE (TOBRAMYCIN AND DEXAMETHASONE) SUSPENSION/ DROPS [SANDOZ INC.]3
TOBRAMYCIN SOLUTION [SANDOZ INC.]3
TOBRAMYCIN SOLUTION [UNIT DOSE SERVICES]3
VICKS SINEX 12 HOUR DECONGESTANT ULTRA FINE MIST MOISTURIZING (OXYMETAZOLINE HYDROCHLORIDE) SPRAY [THE PROCTER & GAMBLE MANUFACTURING COMPANY]3
FLAREX (FLUOROMETHOLONE ACETATE) SUSPENSION [ALCON LABORATORIES, INC.]2
ULTRA FINE MIST PREMIER VALUE (OXYMETAZOLINE HCL NASAL SOLUTION) SPRAY [CHAIN DRUG CONSORTIUM]2
CIPRODEX (CIPROFLOXACIN AND DEXAMETHASONE) SUSPENSION [CLINICAL SOLUTIONS WHOLESALE]1
NASAL MIST CVS (OXYMETAZOLINE HYDROCHLORIDE 0.05%) LIQUID [CVS]1
SOLU-DELTA-CORTEF (PREDNISOLONE SODIUM SUCCINATE, SODIUM PHOSPHATE, MONOBASIC, SODIUM PHOSPHATE, DIBASIC, AND LACTOSE MONOHYDRATE) POWDER [ZOETIS INC.]1
SOOTHE LONG LASTING (POVIDONE) SOLUTION [BAUSCH & LOMB INCORPORATED]1
TOBRADEX (TOBRAMYCIN AND DEXAMETHASONE) SUSPENSION [A-S MEDICATION SOLUTIONS LLC]1
TOBRADEX (TOBRAMYCIN AND DEXAMETHASONE) SUSPENSION [A-S MEDICATION SOLUTIONS LLC]1
TOBRAMYCIN SOLUTION [LAKE ERIE MEDICAL DBA QUAITY CARE PRODUCTS LLC]1
TOBRAMYCIN SOLUTION [PREFERRED PHARMACEUTICALS, INC]1
TOBRAMYCIN SOLUTION [PROFICIENT RX LP]1
TOBRAMYCIN SOLUTION/ DROPS [AKORN, INC.]1
TOBRAMYCIN SOLUTION/ DROPS [HENRY SCHEIN INC.]1
TOBRAMYCIN SOLUTION/ DROPS [MWI]1
TOBRAMYCIN SOLUTION/ DROPS [REMEDYREPACK INC. ]1
TOBRAMYCIN SOLUTION/ DROPS [REMEDYREPACK INC. ]1
VICKS QLEARQUIL 12 HOUR DECONGESTANT MOISTURIZING (OXYMETAZOLINE HYDROCHLORIDE) SPRAY [THE PROCTER & GAMBLE MANUFACTURING COMPANY]1

Inactive Ingredient Database#

Browse recovered IID releases and source provenance.

Current IID rows for UNII Y27PUL9H56 page 1 of 1 · 8 matching rows.

Ingredient, UNII, CAS table
IngredientUNIICASDosage formRoutePotencyMaximum daily exposure
TYLOXAPOLY27PUL9H5625301024SUSPENSIONAURICULAR (OTIC)0.05 %w/v
TYLOXAPOLY27PUL9H5625301024SUSPENSION/ DROPSAURICULAR (OTIC)0.05 %w/v
TYLOXAPOLY27PUL9H5625301024GELOPHTHALMIC0.05 %w/w
TYLOXAPOLY27PUL9H5625301024SOLUTIONOPHTHALMIC5 mg
TYLOXAPOLY27PUL9H5625301024SOLUTION/ DROPSOPHTHALMIC4 mg
TYLOXAPOLY27PUL9H5625301024SUSPENSIONOPHTHALMIC7 mg
TYLOXAPOLY27PUL9H5625301024SUSPENSION/ DROPSOPHTHALMIC0.3 %w/v
TYLOXAPOLY27PUL9H5625301024SUSPENSION/ DROPSTOPICAL0.03 %w/v